Stockscreener 앱 받기
78.21
2.60%
-2.09
시간 외 거래:
80.24
2.03
+2.60%
Illumina Inc 주식(ILMN)의 최신 뉴스
Illumina Leadership to Share Strategic Vision at Prestigious Bernstein Conference May 28 - Stock Titan
Illumina unveils DRAGEN version 4.4 software focusing on oncology applications for clinical research - BioSpectrum India
Illumina, Inc. (ILMN): Among Small-Cap Healthcare Stocks Hedge Funds Are Buying - Insider Monkey
South East Asia Molecular Diagnostics Market Forecast to 2031: PCR Technology Leads Growth, Kits & Reagents Hold Largest Share - GlobeNewswire Inc.
Onco-hematology Molecular Testing Market Top Players - openPR.com
Championing greater health in and outside the office - Illumina
NGS Library Preparation Market Growth Projections | Key Players: Illumina, Thermo Fisher Scientific, Roche - openPR.com
Illumina unveils DRAGEN v4.4 with enhanced accuracy - Investing.com
Illumina DRAGEN v4.4 powers clinical oncology research and multiomic applications - Illumina
Investing in Illumina (ILMN)? Don't Miss Assessing Its International Revenue Trends - Yahoo Finance
Illumina, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions - simplywall.st
Illumina, Inc. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next - Yahoo Finance
Illumina Faces Uncertainties From China Ban, Research Slump, Morgan Stanley Says - marketscreener.com
Morgan Stanley Adjusts Illumina Price Target to $100 From $136, Maintains In Line Rating - marketscreener.com
Functional Genomics Market Top PlayersExact Sciences - openPR.com
Canaccord cuts Illumina stock target to $87, maintains hold By Investing.com - Investing.com India
Canaccord cuts Illumina stock target to $87, maintains hold - Investing.com
Illumina Q1 2025 revenue down 1% to USD 1.04 billion - Medical Buyer
Illumina outlines $4.18B to $4.26B guidance for 2025 amid China headwinds and strategic cost reductions - MSN
Illumina: Multiple Headwinds Point To Limited Upside In 2025 (NASDAQ:ILMN) - Seeking Alpha
Illumina (ILMN) Faces Adjusted Price Target and Positive Earnings Outlook | ILMN Stock News - GuruFocus
Illumina, Inc. (NASDAQ:ILMN) Q1 2025 Earnings Call Transcript - Insider Monkey
Cathie Wood’s ARK buys Shopify, Illumina stock; sells Palantir, Natera - Investing.com
Cathie Wood’s ARK buys Shopify, Illumina stock; sells Palantir, Natera By Investing.com - Investing.com India
Illumina (ILMN) Price Target Lowered by JP Morgan | ILMN Stock N - GuruFocus
SEC ends probe of Illumina’s Grail acquisition - MedTech Dive
TD Cowen raises Illumina stock target to $89, maintains Hold rating - Investing.com
Precision Medicine Market Analysis Report 2024-2030: Bristol-Myers Squibb, Illumina, Merck, AstraZeneca, and Roche Dominate with their Contributions to Research, Product Approvals, and Partnerships - GlobeNewswire
Illumina Q1 Earnings Top Estimates, Revenues Down Y/Y, Stock Dips - Yahoo Finance
Illumina Q1 2025 slides: Revises guidance downward amid China restrictions and tariff impacts - Investing.com
Lab-on-a-Chip Market Insights: Growth, Trends & Forecast - openPR.com
Illumina Inc (ILMN) Q1 2025 Earnings Call Highlights: Navigating Challenges with Strategic ... By GuruFocus - Investing.com Canada
Earnings call transcript: Illumina Q1 2025 beats EPS forecast but faces stock dip - Investing.com
Illumina Reports Q1 2025 Financial Results Amid Challenges - TipRanks
Illumina: Q1 Earnings Snapshot - Norwalk Hour
Illumina (ILMN) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates - Yahoo Finance
Illumina confirms SEC has closed investigation into $8B Grail deal - Endpoints News
Illumina (ILMN) Tops Q1 Earnings and Revenue Estimates - Yahoo Finance
Illumina (ILMN) Shares Drop 3% Despite Beating Q1 EPS Estimates - GuruFocus
Illumina’s (NASDAQ:ILMN) Q1 Sales Top Estimates - Yahoo Finance
Illumina down 3% as lowered 2025 EPS guidance overshadows Q1 top-line beat - MSN
Illumina Cuts Guidance on Threat From Tariffs and China Ban - Bloomberg.com
Digital Genome Market Forecast: Growth Trends, Key Players & - openPR.com
Illumina Reports Financial Results for First Quarter of Fiscal Year 2025 - PR Newswire
Lobbying Update: $620,000 of ILLUMINA INC. lobbying was just disclosed - Nasdaq
Clinical Oncology Next-Generation Sequencing Market Size, - openPR.com
INVESTOR ALERT: Levi & Korsinsky Notifies Shareholders of Illumina, Inc.(ILMN) of a Class Action Lawsuit and an Upcoming Deadline - ACCESS Newswire
Single Cell Genome Sequencing Market Deep Research 2025-2032 | - openPR.com
ILLUMINA Earnings Preview: Recent $ILMN Insider Trading, Hedge Fund Activity, and More - Nasdaq
Here’s Why Artisan Mid Cap Fund Decided to Exit Illumina (ILMN) - Insider Monkey
Earnings To Watch: Illumina (ILMN) Reports Q1 Results Tomorrow - Yahoo Finance
1.15%
자본화:
|
볼륨(24시간):